首页 › 基金 › Lionhunter Capital Management, LLC › TLSI

Lionhunter Capital Management, LLC 对 TLSI 的持仓历史

TRISALUS LIFE SCIENCES INC · 医疗保健

Lionhunter Capital Management, LLC 在 Q2 2026 的 13F 申报中披露持有 TLSI(TRISALUS LIFE SCIENCES INC)300,275 股,市值约 US$1.4M,约占其申报组合的 0.62%,在其申报持仓中市值排名第 45 位。 Lionhunter Capital Management, LLC 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)300.27K 股
申报持仓市值$1.37M
组合权重0.62%
首次申报Q2 2026
最近变动新进
更新于2026-10-09

最后更新: 2026-10-09 · 来源: SEC EDGAR Form 13F-HR

Lionhunter Capital Management, LLC 对 TLSI 的持仓演变

Lionhunter Capital Management, LLC 于 Q2 2026 首次披露 TLSI 持仓:300,275 股(约 US$1.4M)。

逐季持仓明细

季度股数金额变化
Q2 2026 300.27K $1.37M 新进

关于 TLSI 与 13F 数据

TLSI(TRISALUS LIFE SCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 51 只申报持有 TLSI,申报仓位最大的包括:First Light Asset Management, LLC (US$29.8M), WHITE PINE CAPITAL LLC (US$2.5M), PERKINS CAPITAL MANAGEMENT INC (US$1.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 TLSI 的基金

查看 TLSI 的全部基金持有人 →

常见问题

How long has Lionhunter Capital Management, LLC held TLSI?

Lionhunter Capital Management, LLC has disclosed TLSI holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Lionhunter Capital Management, LLC's current position in TLSI?

As of Q2 2026, Lionhunter Capital Management, LLC holds 300.27K shares of TLSI (TRISALUS LIFE SCIENCES INC), valued at $1.37M, representing 0.62% of its reported portfolio and ranking #45.

Has Lionhunter Capital Management, LLC been buying or selling TLSI?

In the latest 13F filing (Q2 2026), Lionhunter Capital Management, LLC newly opened its position in TLSI.

Which other funds hold TLSI?

Other major institutional holders of TLSI include First Light Asset Management, LLC, WHITE PINE CAPITAL LLC, PERKINS CAPITAL MANAGEMENT INC, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.